Drug Info Exam 1

Front 1

Blood Pressure

Back 1

1. Systolic Blood Pressure: occurs immediately after heart contracts.
- Systole: clinical term for contraction of the heart
2. Diastolic Blood Pressure: blood pressure occurring while heart is at rest.
- Diastole: expansion of heart cavities allowing the heart to fill with blood

Front 2

Diagnosis of Hypertension

Back 2

Systolic pressure > 140 mm Hg and/or Diastolic pressure > 90 mm Hg

Front 3

ACE Inhibitors General

Back 3

Renin is an enzyme produced by the kidney. Renin cleaves angiotensinogen and forms Angiotensin I (inactive). ACE coverts Angiotensin I to Angiotensin II (vasoconstrictor). ACE Inhibitors are angiotensin converting enzyme inhibitors that decrease the production of Angiotensin II, which leads to vasodilation.

Front 4

ACE Inhibitors Indications

Back 4

1. Antihypertensive
2. Heart Failure

Front 5

ACE Inhibitors Contraindications

Back 5

1. Do not use in pregnancy (BBW)
- Black Box Warning: information about a medication the FDA considers especially
important (side effects, drug interactions, restrictions on use, etc).
- Drugs that affect the renin angiotensin system can cause birth defects in the 1st trimester
and renal failure in the 2nd and 3rd trimester.
2. Avoid salt substitutes
- Salt substitutes are potassium based and, when used with ACE Inhibitors, can raise the
potassium level, which might result in hyperkalemia (which can leads to cardiac
arrhythmias).
- Normal serum K+ level: 3.5-5 mEq/L.
- Hyperkalemia is defined as serum K+ > 5 mEq/L.

Front 6

Altace

Back 6

ramipril

Front 7

ramipril

Back 7

Altace

Front 8

Lotensin

Back 8

benazepril

Front 9

benazepril

Back 9

Lotensin

Front 10

Monopril

Back 10

fosinopril

Front 11

fosinopril

Back 11

Monopril

Front 12

Univasc

Back 12

moexipril

Front 13

moexipril

Back 13

Univasc

Front 14

Univasc patient counseling

Back 14

Take on an empty stomach because food decreases absorption

Front 15

Mavik

Back 15

trandolapril

Front 16

trandolapril

Back 16

Mavik

Front 17

Accupril

Back 17

quinapril

Front 18

quinapril

Back 18

Accupril

Front 19

Prinivil

Back 19

lisinopril

Front 20

lisinopril

Back 20

Prinivil, Zestril

Front 21

Zestril

Back 21

lisinopril

Front 22

Accuretic

Back 22

quinapril, hydrochlorothiazide

Front 23

quinapril, hydrochlorothiazide

Back 23

Accuretic

Front 24

Prinzide

Back 24

lisinopril, hydrochlorothiazide

Front 25

Zestoretic

Back 25

lisinopril, hydrochlorothiazide

Front 26

lisinopril, hydrochlorothiazide

Back 26

Prinzide, Zestoretic

Front 27

HCTZ

Back 27

HCTZ is a thiazide diuretic. Thiazide diuretics are potassium depleting. Depleting too much potassium could lead to hypokalemia. Remember, the normal serum K+ levels are 3.5-5 mEq/L. Symptoms of hypokalemia are weakness and leg cramps.

Front 28

Lotrel

Back 28

benazepril, amlodipine

Front 29

Tarka

Back 29

trandolapril, verapamil

Front 30

benazepril, amlodipine

Back 30

Lotrel

Front 31

trandolapril, verapamil

Back 31

Tarka

Front 32

Angiotensin II Receptor Antagonists General

Back 32

Angiotensin II Receptor Antagonists do not effect the production of angiotensin II. They just block the receptors so Angiotensin II cannot exert its vasoconstrictor effect.

Front 33

Angiotensin II Receptor Antagonists Indications

Back 33

Antihypertensive

Front 34

Angiotensin II Receptor Antagonists Contraindications

Back 34

1. Do not use in pregnancy (BBW)
- Drugs that affect the renin angiotensin system can cause birth defects in the 1st trimester
and renal failure in the 2nd and 3rd trimester.
2. Avoid salt substitutes
- Salt substitutes are potassium based and, when used with ACE Inhibitors, can raise the
potassium level, which might result in hyperkalemia (which can leads to cardiac
arrhythmias).

Front 35

Diovan

Back 35

valsartan

Front 36

Atacand

Back 36

candesartan

Front 37

Cozaar

Back 37

losartan

Front 38

Micardis

Back 38

telmisartan

Front 39

Avapro

Back 39

irbesartan

Front 40

Benicar

Back 40

olmesartan

Front 41

valsartan

Back 41

Diovan

Front 42

candesartan

Back 42

Atacand

Front 43

losartan

Back 43

Cozaar

Front 44

telmisartan

Back 44

Micardis

Front 45

irbesartan

Back 45

Avapro

Front 46

olmesartan

Back 46

Benicar

Front 47

losartan, hydrochlorothiazide

Back 47

Hyzaar

Front 48

irbesartan, hydrochlorothiazide

Back 48

Avalide

Front 49

Calcium Channel Blockers general

Back 49

Calcium Channel Blockers prevent the entry of Ca+ ions into vascular smooth muscle. Calcium Channel Blockers relax vascular smooth muscle which causes vasodilation.

Front 50

Calcium Channel Blockers Indications

Back 50

Antihypertensive

Front 51

Norvasc

Back 51

amlodipine

Front 52

Calan

Back 52

verapamil

Front 53

Verelan

Back 53

verapamil

Front 54

Sular

Back 54

nisoldipine

Front 55

Cardizem LA

Back 55

diltiazem

Front 56

amlodipine

Back 56

Norvasc

Front 57

verapamil

Back 57

Calan, Verelan

Front 58

nisoldipine

Back 58

Sular

Front 59

diltiazem

Back 59

Cardizem LA

Front 60

Lotrel

Back 60

amlodipine, benazepril

Front 61

Tarka

Back 61

verapamil, trandolapril

Front 62

amlodipine, benazepril

Back 62

Lotrel

Front 63

verapamil, trandolapril

Back 63

Tarka

Front 64

HMG-CoA Reductase Inhibitors General

Back 64

Therapeutic Category: Antihyperlipidemic (lowers serum cholesterol)
Indication: Hyperlipidemia (clinical term for elevated serum cholesterol)
Class: HMG-CoA Reductase Inhibitor

HMG-CoA Reductase Inhibitors inhibit the enzyme HMG-CoA Reductase, which is necessary in cholesterol formation. Therefore if you inhibit HMG-CoA Reductase, less cholesterol is formed.

Front 65

Zocor

Back 65

simvastatin

Front 66

Pravachol

Back 66

pravastatin

Front 67

Crestor

Back 67

rosuvastatin

Front 68

Lipitor

Back 68

atorvastatin

Front 69

simvastatin

Back 69

Zocor

Front 70

pravastatin

Back 70

Pravachol

Front 71

rosuvastatin

Back 71

Crestor

Front 72

atorvastatin

Back 72

Lipitor

Front 73

Caduet

Back 73

atorvastatin, amlodipine

Front 74

atorvastatin, amlodipine

Back 74

Caduet

Front 75

Beta Blockers general

Back 75

Beta Blockers slow down the heart rate. Bradycardia is the clinical term for a slow heart rate (less then 60 beats per minute).

Front 76

Toprol XL

Back 76

metoprolol succinate

Front 77

metoprolol succinate

Back 77

Toprol XL

Front 78

Toprol XL dosage form

Back 78

Extended release tablet given once daily

Front 79

Lopressor

Back 79

metoprolol tartrate

Front 80

metoprolol tartrate

Back 80

Lopressor

Front 81

Lopressor dosage form

Back 81

- Immediate release tablet give 2 to 3 times daily.
- Toprol XL and Lopressor are not substitutable for one another because they contain different salt formulations.

Front 82

Coreg

Back 82

carvedilol

Front 83

carvedilol

Back 83

Coreg
Coreg CR

Front 84

Coreg dosage form

Back 84

Immediate release tablet given twice daily

Front 85

Coreg CR dosage form

Back 85

Extended release capsule given once daily
Can open capsule and sprinkle beads on food that is NOT chewed. If beads are chewed then dose dumping can occur
Take with food to decrease chance of orthostatic hypotension (fall in blood pressure upon standing). Can be severe enough to cause fainting

Front 86

clinical term for fainting

Back 86

syncope

Front 87

Inderal LA

Back 87

propranolol

Front 88

propranolol

Back 88

Inderal LA

Front 89

Inderal LA dosage form

Back 89

Extended release capsule given once daily
Also indicated for migraine prophylaxis (clinical term for prevention = prophylaxis)

Front 90

Sectral

Back 90

acebutolol

Front 91

acebutolol

Back 91

Sectral

Front 92

Zebeta

Back 92

bisoprolol

Front 93

bisoprolol

Back 93

Zebeta

Front 94

Tenormin

Back 94

atenolol

Front 95

atenolol

Back 95

Tenormin

Front 96

Ziac

Back 96

bisoprolol, hydrochlorothiazide

Front 97

bisoprolol, hydrochlorothiazide

Back 97

Ziac

Front 98

Tenoretic

Back 98

atenolol, chlorthalidone

Front 99

atenolol, chlorthalidone

Back 99

Tenoretic

Front 100

Hygroton

Back 100

chlorthalidone

Front 101

chlorthalidone

Back 101

Hygroton

Front 102

Hygroton therapeutic category

Back 102

thiazide diuretic (potassium depleting)

Front 103

Catapres TTS

Back 103

clonidine

Front 104

clonidine

Back 104

Catapres TTS

Front 105

Catapres TTS general

Back 105

a. Therapeutic Category: Antihypertensive
b. TTS = transdermal therapeutic system
c. Strengths (expressed in release rates): 0.1 mg/ 24 hr
0.2 mg/ 24 hr
0.3 mg/ 24 hr
d. Dosing Interval: once weekly
e. Catapres (clonidine) : tablet dosage form

Front 106

SALAD with clonidine

Back 106

Klonopin (clonazepam); Klonopin is a benzodiazepine indicated for panic attacks and anxiety

Front 107

clinical term for a drug that reduces anxiety

Back 107

Anxiolytic

Front 108

Digitek

Back 108

digoxin

Front 109

digoxin

Back 109

Lanoxin, Digitek

Front 110

Lanoxin, Digitek dosage forms

Back 110

a. Strengths/ Dosage Form
i. 0.125 mg tablet
ii. 0.25 mg tablet
iii. 0.05 mg/mL elixir

Front 111

digoxin Indications

Back 111

i. Heart Failure (0.5-0.8 ng/mL)
ii. Different types of arrhythmias (0.8-2 ng/mL)

Front 112

clinical term for irregular heart beat

Back 112

Arrhythmia

Front 113

Digoxin effects

Back 113

Digoxin exerts a positive inotropic action (it makes the heart beat stronger). Inotropic means affecting the force or energy of muscular contraction (either positive or negative).

Front 114

example of a drug that exerts a negative inotropic action

Back 114

Sporanox (itraconazole)

Front 115

Black Box Warning for Sporanox

Back 115

do not use in patients with heart failure

Front 116

Patient Counseling with digoxin

Back 116

May cause nausea, vomiting, or vision problems (digoxin toxicity)

Front 117

Antiplatelet Agents indications

Back 117

indicated to decrease the incidence of a heart attack or stroke in high risk patients (such as patients who have previously had a heart attack or stroke).

Front 118

Plavix

Back 118

clopidogrel

Front 119

Aggrenox

Back 119

aspirin, dipyridamole

Front 120

aspirin, dipyridamole

Back 120

Aggrenox

Front 121

clopidogrel

Back 121

Plavix

Front 122

Coumadin

Back 122

warfarin sodium

Front 123

Ticlid

Back 123

ticlopidine

Front 124

ticlopidine

Back 124

Ticlid

Front 125

warfarin sodium

Back 125

Coumadin

Front 126

Coumadin therapeutic category

Back 126

Anticoagulant

Front 127

Coumadin indication

Back 127

indicated for treatment and prevention of thrombosis

Front 128

presence of a thrombus

Back 128

Thrombosis

Front 129

clinical term for blood clot

Back 129

Thrombus

Front 130

Coumadin MOA

Back 130

inhibits the synthesis of the four vitamin K dependent clotting factors II, VII, IX, and X. Without the vitamin K dependent clotting factors, clot formation is decreased.

Front 131

Vitamin K and Coumadin

Back 131

i. A large intake of Vitamin K can decrease Coumadin’s effectiveness because it will stimulate the formation of Vitamin K clotting factors.
ii. Vitamin K is found in Multivitamins, green leafy vegetables (such as spinach, broccoli, and lettuce) and in green tea.
iii. Large intake of Vitamin K can equal maybe an increase in Coumadin dose.

Front 132

Coumadin Black Box Warning

Back 132

may case major or fatal bleeding

Front 133

Neurotransmitters

Back 133

Epinephrine, Norepinephrine, Serotonin, and Dopamine

Front 134

Selective serotonin reuptake inhibitors (general)

Back 134

raise 5HT levels in the brain; usually take 2-3 weeks to work.

Front 135

Indications for SSRIs

Back 135

i. Depression
ii. Panic Disorder
iii. Obsessive Compulsive Disorder (OCD)
iv. Post Traumatic Stress Disorder (PTSD)
v. Premenstrual Dysphoric Disorder (PMDD)

Front 136

Lexapro

Back 136

escitalopram

Front 137

escitalopram

Back 137

Lexapro

Front 138

Paxil CR

Back 138

paroxetine hydrochloride

Front 139

paroxetine hydrochloride

Back 139

Paxil CR

Front 140

Pexeva

Back 140

paroxetine mesylate

Front 141

paroxetine mesylate

Back 141

Pexeva

Front 142

Paxil CR dosage

Back 142

controlled release tablet

Front 143

Zoloft

Back 143

sertraline

Front 144

sertraline

Back 144

Zoloft

Front 145

Prozac

Back 145

fluoxetine

Front 146

fluoxetine

Back 146

Prozac

Front 147

Selective serotonin and norepinephrine reuptake inhibitors (SSNRIs) general

Back 147

raise 5HT and NE levels in the brain.

Front 148

Pristiq general

Back 148

active metabolite of venlafaxine

Front 149

Cymbalta indication

Back 149

also indicated for DPN (diabetic peripheral neuropathy)

Front 150

Pexeva dosage

Back 150

ifferent salt form than Paxil (can not substitute generic Paxil for Pexeva)

Front 151

Zyban

Back 151

bupropion

Front 152

Effexor XR

Back 152

venlafaxine

Front 153

venlafaxine

Back 153

Effexor XR

Front 154

Pristiq

Back 154

desvenlafaxine

Front 155

desvenlafaxine

Back 155

Pristiq

Front 156

Cymbalta

Back 156

duloxetine

Front 157

duloxetine

Back 157

Cymbalta

Front 158

Wellbutrin

Back 158

bupropion

Front 159

bupropion

Back 159

Wellbutrin (SR, XL), Zyban

Front 160

Wellbutrin, SR, XL dosage

Back 160

Wellbutrin (bupropion) -- three times daily
Wellbutrin SR (bupropion) -- twice daily
Wellbutrin XL (bupropion) -- once daily

Front 161

Zyban indication and dosage

Back 161

i. Indicated for smoking cessation
ii. 150 mg bupropion sustained release tablet
iii. Dosing Interval: 1 tablet every day for 3 days, then 1 tablet twice daily (x12 wks)

Front 162

Wellbutrin category

Back 162

aminoketone

Front 163

SSRI's examples

Back 163

Lexapro, Paxil, Pexeva, Zoloft, Prozac

Front 164

SSNRI's examples

Back 164

Effexor XR, Pristiq, Cymbalta

Front 165

Remeron category

Back 165

tetracyclic

Front 166

Remeron

Back 166

mirtazapine

Front 167

mirtazapine

Back 167

Remeron
Remeron SolTab

Front 168

Tricyclic examples

Back 168

amitriptyline
Pamelor

Front 169

Typical/Conventional Antipsychotics

Back 169

Phenothiazines
i. prochlorperazine
ii. Trilafon (perphenazine)
iii. Prolixin (fluphenazine)
Butyrophenone
i. haloperidol

Front 170

Pamelor

Back 170

nortriptyline

Front 171

nortriptyline

Back 171

Pamelor

Front 172

Atypical/Novel Antipsychotics

Back 172

Dibenzepines
i. Seroquel (quetiapine)
ii. Zyprexa (olanzapine) -- tablet
iii. Zyprexa Zydis (olanzapine) -- orally disintegrating tablet
Benzisoxazoles
iv. Risperdal (risperidone) -- tablet
- new indication of risperidone = autism (only antipsychotic indicated for autism)
v. Risperdal M-Tab (risperidone) -- orally disintegrating tablet
vi. Invega (paliperidone) -- active metabolite of risperidone
Quinolinone
vii. Abilify (aripiprazole) -- tablet
- new indication of aripiprazole = depression (only antipsychotic indicated for depression)
viii. Abilify Discmelt (aripiprazole) -- orally disintegrating tablet
Dihydroindolone
ix. Geodon (ziprasidone)

Front 173

prochlorperazine category

Back 173

Phenothiazines

Front 174

Trilafon category

Back 174

Phenothiazines

Front 175

Prolixin category

Back 175

Phenothiazines

Front 176

haloperidol category

Back 176

Butyrophenone

Front 177

Trilafon

Back 177

perphenazine

Front 178

perphenazine

Back 178

Trilafon

Front 179

Prolixin

Back 179

fluphenazine

Front 180

fluphenazine

Back 180

Prolixin

Front 181

Seroquel category

Back 181

Dibenzepines

Front 182

Zyprexa category

Back 182

Dibenzepines

Front 183

Risperdal category

Back 183

Benzisoxazoles

Front 184

Seroquel

Back 184

quetiapine

Front 185

quetiapine

Back 185

Seroquel

Front 186

Zyprexa

Back 186

olanzapine

Front 187

olanzapine

Back 187

Zyprexa

Front 188

Risperdal

Back 188

risperidone

Front 189

risperidone

Back 189

Risperdal

Front 190

Invega

Back 190

paliperidone

Front 191

paliperidone

Back 191

Invega

Front 192

Invega category

Back 192

Benzisoxazoles

Front 193

new indication of risperidone

Back 193

autism (only antipsychotic indicated for autism)

Front 194

Abilify

Back 194

aripiprazole

Front 195

aripiprazole

Back 195

Abilify

Front 196

Geodon

Back 196

ziprasidone

Front 197

ziprasidone

Back 197

Geodon

Front 198

Geodon category

Back 198

Dihydroindolone

Front 199

new indication of aripiprazole

Back 199

depression (only antipsychotic indicated for depression)

Front 200

Abilify category

Back 200

Quinolinone

Front 201

Seizures types

Back 201

A. Partial- involves just one hemisphere of brain and may or may not impair consciousness
B. Generalized- affects both hemispheres of brain and impairs consciousness
i. tonic-clonic
ii. absence (synonym = “Petit Mal”)

Front 202

Lyrica

Back 202

pregabalin

Front 203

pregabalin

Back 203

Lyrica

Front 204

Lyrica indications

Back 204

i. partial seizures
ii. pain associated with Post Herpetic Neuralgia (PHN=shingles: persistent pain in area of shingles that persist after blisters have healed)
iii. pain associated with Diabetic Peripheral Neuropathy (DPN)
iv. fibromyalgia

Front 205

Topamax indications

Back 205

i. partial seizures
ii. tonic-clonic seizures
iii. migraine prophylaxis

Front 206

Topamax

Back 206

topiramate

Front 207

topiramate

Back 207

Topamax

Front 208

Depakote

Back 208

divalproex

Front 209

divalproex

Back 209

Depakote

Front 210

divalproex indications

Back 210

i. partial seizures
ii. absence seizures
iii. manic episodes of bipolar disorder
iv. migraine prophylaxis

Front 211

Keppra Indications

Back 211

i. partial seizures
ii. tonic-clonic seizures

Front 212

Keppra

Back 212

levetiracetam

Front 213

levetiracetam

Back 213

Keppra

Front 214

Dilantin

Back 214

phenytoin

Front 215

phenytoin

Back 215

Dilantin

Front 216

Dilantin Infatab dosage

Back 216

50 mg chewable tablet

Front 217

Dilantin Class

Back 217

hydantoin

Front 218

phenytoin indications

Back 218

i. partial seizures
ii. tonic-clonic seizures

Front 219

Dilantin dosage

Back 219

30 mg and 100 mg capsule; 125 mg/ 5 mL oral suspension

Front 220

Trileptal indications

Back 220

partial seizures

Front 221

Trileptal

Back 221

oxcarbazepine

Front 222

oxcarbazepine

Back 222

Trileptal

Front 223

Lamictal

Back 223

lamotrigine

Front 224

lamotrigine

Back 224

Lamictal

Front 225

Lamictal SALAD

Back 225

Lamisil (terbinafine)

Front 226

Lamisil category

Back 226

antifungal

Front 227

Lamisil

Back 227

terbinafine

Front 228

terbinafine

Back 228

Lamisil

Front 229

Lamictal indications

Back 229

i. partial seizures
ii. tonic-clonic seizures
iii. bipolar disorder (both manic and depression)

Front 230

Neurontin indications

Back 230

i. partial seizures
ii. pain associated with PHN

Front 231

Neurontin

Back 231

gabapentin

Front 232

gabapentin

Back 232

Neurontin

Front 233

agents used to induce sleep

Back 233

Hypnotics

Front 234

Ambien category

Back 234

imidazopyridine

Front 235

Ambien

Back 235

zolpidem

Front 236

zolpidem

Back 236

Ambien (CR)

Front 237

Lunesta category

Back 237

cyclopyrrolone

Front 238

Rozerem category

Back 238

melatonin receptor agonist

Front 239

Adderall dosage

Back 239

a. Immediate release tablet
b. Dosing Interval: once or twice daily

Front 240

Lunesta

Back 240

eszopiclone

Front 241

eszopiclone

Back 241

Lunesta

Front 242

Rozerem

Back 242

ramelteon

Front 243

ramelteon

Back 243

Rozerem

Front 244

Adderall XR

Back 244

dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate

Front 245

dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate

Back 245

Adderall XR

Front 246

Adderall XR dosage

Back 246

a. Extended release capsule
b. Dosing Interval: once daily

Front 247

Adderall XR indications

Back 247

i. Attention Deficit Hyperactivity Disorder (ADHD)
ii. Narcolepsy

Front 248

Concerta dosage

Back 248

a. Extended release tablet
b. Dosing Interval: once daily

Front 249

Concerta

Back 249

methylphenidate

Front 250

methylphenidate

Back 250

Concerta, Methylin, Ritalin

Front 251

Methylin

Back 251

methylphenidate

Front 252

Ritalin

Back 252

methylphenidate

Front 253

Focalin XR

Back 253

dexmethylphenidate

Front 254

dexmethylphenidate

Back 254

Focalin XR

Front 255

Concerta indications

Back 255

i. Attention Deficit Hyperactivity Disorder (ADHD)

Front 256

Methylin dosage

Back 256

a. Immediate release tablet
b. Dosing Interval: once to three times daily

Front 257

Methylin indications

Back 257

i. Attention Deficit Hyperactivity Disorder (ADHD)
ii. Narcolepsy

Front 258

Ritalin dosage

Back 258

a. Immediate release tablet
b. Dosing Interval: once to three times daily

Front 259

Ritalin indications

Back 259

i. Attention Deficit Hyperactivity Disorder (ADHD)
ii. Narcolepsy

Front 260

Focalin XR dosage

Back 260

a. Extended release capsule
b. Dosing Interval: once daily
Dextro (active) isomer of methylphenidate. Requires only ½ the dose

Front 261

Focalin XR indications

Back 261

i. Attention Deficit Hyperactivity Disorder (ADHD)

Front 262

Focalin dosage

Back 262

a. Immediate release tablet
b. Dosing Interval: twice daily

Front 263

Provigil

Back 263

modafinil

Front 264

modafinil

Back 264

Provigil

Front 265

Provigil dosage

Back 265

a. Immediate release tablet
b. Dosing Interval: once daily

Front 266

Provigil indications

Back 266

i. Narcolepsy
ii. Shift work sleep disorder (SWSD)

Front 267

Focalin indications

Back 267

i. Attention Deficit Hyperactivity Disorder (ADHD)

Front 268

Provigil general

Back 268

DEA Schedule IV controlled substance

Front 269

Strattera

Back 269

atomoxetine

Front 270

atomoxetine

Back 270

Strattera

Front 271

Strattera category

Back 271

Selective Norepinephrine Reuptake Inhibitor

Front 272

Strattera dosage

Back 272

b. Immediate release capsule
c. Dosing Interval: once or twice daily

Front 273

Strattera indications

Back 273

Attention Deficit Hyperactivity Disorder (ADHD)

Front 274

Strattera general

Back 274

Not a controlled substance

Front 275

Requip

Back 275

ropinirole

Front 276

ropinirole

Back 276

Requip

Front 277

Requip category

Back 277

Antiparkinson Agent

Front 278

Requip class (not category)

Back 278

Dopamine Receptor Agonist-- Drug combines with receptor and produces a dopamine like effect. Dopamine is the neurotransmitter that allows control of movement.

Front 279

Requip indications and dosage

Back 279

i. Parkinson’s Disease -- three times daily
ii. Restless Legs Syndrome (RLS) -- once daily one to three hours before bedtime

Front 280

Mirapex category

Back 280

Antiparkinson Agent

Front 281

Mirapex

Back 281

pramipexole

Front 282

pramipexole

Back 282

Mirapex

Front 283

Mirapex class (category)

Back 283

Dopamine Receptor Agonist-- Drug combines with receptor and produces a dopamine like effect. Dopamine is the neurotransmitter that allows control of movement.

Front 284

Mirapex indications and dosage

Back 284

i. Parkinson’s Disease -- three times daily
ii. Restless Legs Syndrome (RLS) -- once daily one to three hours before bedtime